Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 387.50
-2.50 (-0.64%)
Mar 4, 2026, 9:35 AM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.24 billion as of March 3, 2026. Its market cap has increased by 43.12% in one year.
Market Cap
21.24B
Enterprise Value
20.63B
Revenue
2.00B
Ranking
n/a
PE Ratio
29.66
Stock Price
387.50
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.24B, an increase of 1,328.34%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 21.57B | - |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 33.79B |
| Lumosa Therapeutics | 29.14B |
| Oneness Biotech | 28.47B |
| Polaris Group | 25.66B |
| EirGenix | 18.34B |
| AP Biosciences | 15.15B |
| TaiMed Biologics | 14.04B |
| Ever Supreme Bio Technology | 13.49B |